DOYLESTOWN, Pa. - Aprea Therapeutics, Inc. (NASDAQ: NASDAQ:APRE), a biopharmaceutical company with a market capitalization of $21.2 million focused on developing treatments targeting cancer cell ...
Vistagen (VTGN) announced that the U.S. Patent and Trademark Office or USPTO, granted a patent to the company for its oral non-opioid product ...
Insight Innovation Fund (IIFund) today announced the launch of its groundbreaking venture capital fund that combines proprietary artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback